腹腔镜对比开腹切除结直肠癌肝转移的生存优势:随机试验与倾向评分匹配研究的个体患者数据Meta分析
该研究利用计算机视觉从2项随机试验和13项倾向评分匹配研究重建3148例患者的个体生存数据,采用频率学派和贝叶斯生存模型比较腹腔镜与开腹肝切除治疗结直肠癌肝转移的总体生存。结果显示腹腔镜组死亡风险显著降低(分层HR=0.853,95%CI 0.754-0.965,P=0.0114),10年限制性平均生存时间延长8.6个月(12.1%),长期癌症幸存者比例分别为47.4%和18.0%。结论认为腹腔镜至少不劣于开腹手术,并可能具有长期生存优势。
要点
- 腹腔镜组死亡风险显著低于开腹组(分层HR=0.853,95%CI 0.754-0.965,P=0.0114)。
- 腹腔镜组10年限制性平均生存时间延长8.6个月(12.1%),长期幸存者比例47.4% vs 18.0%。
- ≥65岁老年患者腹腔镜组3年平均预期寿命延长6.2%(P=0.018)。
核心结论
- 腹腔镜切除结直肠癌肝转移在长期生存上优于开腹切除,至少不劣于开腹手术。
研究设计与样本
- 基于2项随机试验和13项倾向评分匹配研究的个体患者数据Meta分析,共3148例参与者。
- 从已发表的Kaplan-Meier曲线利用计算机视觉程序重建个体生存信息。
- 采用频率学派和贝叶斯生存模型(考虑随机效应和非比例风险)比较总体生存。
- 使用治愈模型估计有效治愈的患者比例。
主要发现
- 腹腔镜组死亡风险显著降低(分层HR=0.853,95%CI 0.754-0.965,P=0.0114)。
- 存在时间变化效应(P=0.0324),风险比随时间增大。
- 长期癌症幸存者比例腹腔镜组47.4%,开腹组18.0%。
- 10年随访时腹腔镜组限制性平均生存时间延长8.6个月(12.1%)(P<0.0001)。
- ≥65岁老年患者腹腔镜组3年平均预期寿命延长6.2%(P=0.018),超过5年里程碑者(46.1%)似乎已治愈。
临床怎么用
- 对于结直肠癌肝转移患者,腹腔镜肝切除可作为开腹手术的替代选择,尤其适用于老年患者。
- 腹腔镜手术可能带来长期生存获益,但需结合患者具体情况个体化决策。
局限性
- 个体患者数据从已发表Kaplan-Meier曲线重建,可能存在信息偏倚。
- 纳入研究包括随机试验和倾向评分匹配研究,存在异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To perform an individual participant data meta-analysis using randomized trials and propensity-score matched (PSM) studies which compared laparoscopic versus open hepatectomy for patients with colorectal liver metastases (CLM). BACKGROUND: Randomized trials and PSM studies constitute the highest level of evidence in addressing the long-term oncologic efficacy of laparoscopic versus open resection for CLM. However, individual studies are limited by the reporting of overall survival in ways not amenable to traditional methods of meta-analysis, and violation of the proportional hazards assumption. METHODS: Survival information of individual patients was reconstructed from the published Kaplan-Meier curves with the aid of a computer vision program. Frequentist and Bayesian survival models (taking into account random-effects and nonproportional hazards) were fitted to compare overall survival of patients who underwent laparoscopic versus open surgery. To handle long plateaus in the tails of survival curves, we also exploited "cure models" to estimate the fraction of patients effectively "cured" of disease. RESULTS: Individual patient data from 2 randomized trials and 13 PSM studies involving 3148 participants were reconstructed. Laparoscopic resection was associated with a lower hazard rate of death (stratified hazard ratio = 0.853, 95% confidence interval: 0.754-0.965, P = 0.0114), and there was evidence of time-varying effects (P = 0.0324) in which the magnitude of hazard ratios increased over time. The fractions of long-term cancer survivors were estimated to be 47.4% and 18.0% in the laparoscopy and open surgery groups, respectively. At 10-year follow-up, the restricted mean survival time was 8.6 months (or 12.1%) longer in the laparoscopy arm (P < 0.0001). In a subgroup analysis, elderly patients (≥65 years old) treated with laparoscopy experienced longer 3-year average life expectancy (+6.2%, P = 0.018), and those who live past the 5-year milestone (46.1%) seem to be cured of disease. CONCLUSIONS: This patient-level meta-analysis of high-quality studies demonstrated an unexpected survival benefit in favor of laparoscopic over open resection for CLM in the long-term. From a conservative viewpoint, these results can be interpreted to indicate that laparoscopy is at least not inferior to the standard open approach.
引用
- Syn NL, Kabir T, Koh YX, et al. Survival Advantage of Laparoscopic Versus Open Resection For Colorectal Liver Metastases: A Meta-analysis of Individual Patient Data From Randomized Trials and Propensity-score Matched Studies. Ann Surg. 2020. PMID: 32675538. doi:10.1097/SLA.0000000000003672
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。